Literature DB >> 8887581

Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma.

M Chan-Yeung1, J H Chang, J Manfreda, A Ferguson, A Becker.   

Abstract

Changes in symptom score and peak expiratory flow (PEF) and the use of medications during the first acute exacerbation of asthma were studied in 41 patients and matched controls who took part in a panel study. An acute exacerbation was defined as the presence of at least one of the following: any unscheduled physician visit, visit to an emergency room, or hospitalization for treatment of asthma; a decrease in PEF by 30% from the patient's best reading; an increase in asthma symptoms during the day and night for over 48 h and not responding to usual medications; and the commencement or doubling of the dose of oral or inhaled steroids for any of the foregoing reasons. Data from -9 to -7 d before the onset of an acute exacerbation were taken as the baseline data, with which the values of the subsequent 14 d were compared. Significant increases in symptoms occurred before a significant reduction in PEF. None of the patients had a decrease of more than 30% in PEF before the onset of symptoms. Daily variation in PEF was not significantly increased from the baseline. Our results suggest that PEF monitoring is not as sensitive as a symptom diary for revealing acute exacerbations of asthma, and that a 30% decrease in PEF is too stringent a criterion for defining an acute exacerbation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887581     DOI: 10.1164/ajrccm.154.4.8887581

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

Review 1.  Severe acute asthma.

Authors:  S Salmeron; M Bard; F X Blanc; A Ellrodt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Written action plans for asthma: an evidence-based review of the key components.

Authors:  P G Gibson; H Powell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

3.  Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

Authors:  J M FitzGerald; A Becker; M R Sears; S Mink; K Chung; J Lee
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 4.  Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  L Fabbri; B Beghé; G Caramori; A Papi; M Saetta
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

Review 5.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

Review 6.  Asthma exacerbations . 4: Prevention.

Authors:  J M FitzGerald; P G Gibson
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 8.  Predicting asthma exacerbations in children.

Authors:  Erick Forno; Juan C Celedón
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

9.  Predictors of symptoms are different from predictors of severe exacerbations from asthma in children.

Authors:  Ann Chen Wu; Kelan Tantisira; Lingling Li; Brooke Schuemann; Scott T Weiss; Anne L Fuhlbrigge
Journal:  Chest       Date:  2011-02-03       Impact factor: 9.410

10.  Peak flow measurements in children with asthma: what happens at school?

Authors:  Roni Grad; Leslie McClure; Sijon Zhang; Joan Mangan; Linda Gibson; Lynn Gerald
Journal:  J Asthma       Date:  2009-08       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.